The scrip was listed at a price of Rs 542.30 apiece, at a premium of 2.13% as compared with issue price.

The stock has hit a high of 588.05 and a low of 533.65 so far in the trading session. More than 3.95 lakh shares of the company changed hands in the counter so far.

The initial public offer (IPO) of Vijaya Diagnostic Centre received bids for 11.36 crore shares as against 2.50 crore shares, according to stock exchange data. The issue was subscribed 4.54 times.

The qualified institutional buyers (QIBs) category was subscribed 13.07 times. The non-institutional investors (NIIs) category was subscribed 1.32 times. The retail individual investors (RIIs) category was subscribed 1.09 times.

The issue opened for bidding on Wednesday (1 September 2021) and closed on Friday (3 September 2021). The price band of the IPO was fixed at Rs 522-531 per share.

The IPO was a pure offer for sale of 35.68 crore shares by Dr. S. Surendranath Reddy, Karakoram and Kedaara Capital Alternative Investment Fund (AIF)-1. The company will not raise fresh capital for its business from the IPO.

Ahead of the IPO, Vijaya Diagnostic Centre on 31 August 2021 finalized allocation of 1,06,61,418 equity shares to anchor investors, at Rs 531 per equity share, aggregating to Rs 566.12 crore.

Vijaya Diagnostic offers one-stop solution for pathology and radiology testing services to the customers through extensive operational network, which consists of 80 diagnostic centers and 11 reference laboratories across 13 cities and towns in the states of Telangana and Andhra Pradesh and in the National Capital Region and Kolkata on 30 June 2021.

The company reported net profit of Rs 32.94 crore and sales of Rs 122.69 crore for the quarter ended 30 June 2021.